Discovery and resupply of pharmacologically active plant-derived natural products: A review.
Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H. · 2015
Read Discovery and resupply of pharmacologically active plant-derived natural products: A review. by Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4748402.txt.
Introduction
Atanasov and nineteen co-workers take stock of drug hunting in plants. Plants gave medicine many of its best drugs, from pain care to cancer care. In past decades, drug firms turned to lab-made compounds, which are easy to make in bulk and easy to test fast. New drugs grew scarce, and interest in plants rose again.
The review traces the field's past and its main paths, from folk use to computer models. It lists plant compounds now in trials with patients. The hard part is supply. A drug needs far more of a compound than a first test does, and picking the plant again seldom yields enough. Making the compound in microbes, plant cells, or by full lab synthesis offers a way out.
Catalog record
| CREATOR | Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 243 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |